Canopy Has Global Potential Amid Foggy U.S. Market
The cannabis company took a hit on Q2 earnings, but consumer demand is expected to increase.
On Nov. 14, Canopy (CGC) reported second-quarter results highlighted by product mix challenges due to an unexpected and dramatic hit to revenue and profits. After overproducing oil and softgel for the Canadian recreational market, the company had to accept returns and price reductions that led to a CAD 33 million restructuring charge. Management also scaled back its previous goal of CAD 250 million in net revenue in the fourth quarter of fiscal 2020 because of insufficient points of retail sales in the near term. We always questioned the wisdom of setting a target when provincial governments' slow rollout of stores has held back the industry, so the retraction makes sense to us. We maintain our no-moat rating.
We view the announced restructuring charge as a disconnect between the cannabis forms Canopy produced and those that customers wanted, and not reflective of oversupply of cannabis in general. Kilogram equivalents sold increased 397% year over year to 10,913 kilograms, which the Canadian recreational market and international medical market boosted. Furthermore, the business-to-consumer retail channel saw sequential growth of 24% from the first fiscal-year quarter. As cannabis 2.0 rolls out and more consumer-packaged goods will be available for sale, customer demand is expected to increase for these new cannabis products.
Kristoffer Inton does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.